Battle to define community benefits continues; Not-for-profit hospitals had rough 2008;

> The battle to define community benefits and set minimum charity care levels continues, despite the failure by supporters to get such measures included in the stimulus package. FierceHealthFinance

> According to ratings organization Moody's, not-for-profit hospital financial results worsened in 2008. FierceHealthFinance

> Roche's Japanese unit, Chugai Pharmaceutical, has admitted that its rheumatoid arthritis treatment Actemra might be linked to the deaths of 15 Japanese patients. FiercePharma

> Facial rejuvenation treatment Botox may soon have a couple of international competitors fighting for market share in the U.S, including muscle relaxant Azzalure and Botox rival Reloxin. FiercePharma

And Finally... Getting mad at your kid's school principal isn't unusual. Biting him, well, that's a bit over the top. Article